Induced Pluripotent Stem Cells Generated from Diabetic Patients with Mitochondrial DNA A3243G Mutation

Overview

Journal Diabetologia

Specialty Endocrinology

Date 2012 Mar 8

PMID 22396012

Citations 43

Authors

J Fujikura

M Sone

M Noguchi

E Mori

M Naito

D Taura

M Harada-Shiba

I Kishimoto

A Watanabe

I Asaka

K Hosoda

K Nakao

Affiliations

Soon will be listed here.

Abstract

Aims/hypothesis: The aim of this study was to generate induced pluripotent stem (iPS) cells from patients with mitochondrial DNA (mtDNA) mutation.

Methods: Skin biopsies were obtained from two diabetic patients with mtDNA A3243G mutation. The fibroblasts thus obtained were infected with retroviruses encoding OCT4 (also known as POU5F1), SOX2, c-MYC (also known as MYC) and KLF4. The stem cell characteristics were investigated and the mtDNA mutation frequencies evaluated by Invader assay.

Results: From the two diabetic patients we isolated four and ten putative mitochondrial disease-specific iPS (Mt-iPS) clones, respectively. Mt-iPS cells were cytogenetically normal and positive for alkaline phosphatase activity, with the pluripotent stem cell markers being detectable by immunocytochemistry. The cytosine guanine dinucleotide islands in the promoter regions of OCT4 and NANOG were highly unmethylated, indicating epigenetic reprogramming to pluripotency. Mt-iPS clones were able to differentiate into derivatives of all three germ layers in vitro and in vivo. The Mt-iPS cells exhibited a bimodal degree of mutation heteroplasmy. The mutation frequencies decreased to an undetectable level in six of 14 clones, while the others showed several-fold increases in mutation frequencies (51-87%) compared with those in the original fibroblasts (18-24%). During serial cell culture passage and after differentiation, no recurrence of the mutation or no significant changes in the levels of heteroplasmy were seen.

Conclusions/interpretation: iPS cells were successfully generated from patients with the mtDNA A3243G mutation. Mutation-rich, stable Mt-iPS cells may be a suitable source of cells for human mitochondrial disease modelling in vitro. Mutation-free iPS cells could provide an unlimited, disease-free supply of cells for autologous transplantation therapy.

Citing Articles

Increased mitochondrial mutation heteroplasmy induces aging phenotypes in pluripotent stem cells and their differentiated progeny.

Vandiver A, Torres Jr A, Sanden A, Nguyen T, Gasilla J, Doan M Aging Cell. 2024; 24(3):e14402.

PMID: 39680477 PMC: 11896400. DOI: 10.1111/acel.14402.

A Youthful Touch: Reversal of Aging Hallmarks by Cell Reprogramming.

Miliotou E, de Lazaro I Cells Tissues Organs. 2024; 213(6):538-550.

PMID: 38768583 PMC: 11633886. DOI: 10.1159/000539415.

Metabolic control of induced pluripotency.

Sinenko S, Tomilin A Front Cell Dev Biol. 2024; 11:1328522.

PMID: 38274274 PMC: 10808704. DOI: 10.3389/fcell.2023.1328522.

Mitochondrial Inheritance Following Nuclear Transfer: From Cloned Animals to Patients with Mitochondrial Disease.

Burgstaller J, Chiaratti M Methods Mol Biol. 2023; 2647:83-104.

PMID: 37041330 DOI: 10.1007/978-1-0716-3064-8_4.

Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids.

Tolle I, Tiranti V, Prigione A EMBO Rep. 2023; 24(4):e55678.

PMID: 36876467 PMC: 10074100. DOI: 10.15252/embr.202255678.

References

Ebert A, Yu J, Rose Jr F, Mattis V, Lorson C, Thomson J . Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2008; 457(7227):277-80. PMC: 2659408. DOI: 10.1038/nature07677. View

Lyamichev V, Mast A, Hall J, Prudent J, Kaiser M, Takova T . Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol. 1999; 17(3):292-6. DOI: 10.1038/7044. View

Harvey A, Gibson T, Lonergan T, Brenner C . Dynamic regulation of mitochondrial function in preimplantation embryos and embryonic stem cells. Mitochondrion. 2010; 11(5):829-38. DOI: 10.1016/j.mito.2010.12.013. View

Leonard J, Schapira A . Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects. Lancet. 2000; 355(9201):389-94. DOI: 10.1016/s0140-6736(99)05226-5. View

Williams R, Salmons S, Newsholme E, KAUFMAN R, Mellor J . Regulation of nuclear and mitochondrial gene expression by contractile activity in skeletal muscle. J Biol Chem. 1986; 261(1):376-80. View

Taura D, Noguchi M, Sone M, Hosoda K, Mori E, Okada Y . Adipogenic differentiation of human induced pluripotent stem cells: comparison with that of human embryonic stem cells. FEBS Lett. 2009; 583(6):1029-33. DOI: 10.1016/j.febslet.2009.02.031. View

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K . Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007; 131(5):861-72. DOI: 10.1016/j.cell.2007.11.019. View

Liu J, Verma P, Evans-Galea M, Delatycki M, Michalska A, Leung J . Generation of induced pluripotent stem cell lines from Friedreich ataxia patients. Stem Cell Rev Rep. 2010; 7(3):703-13. DOI: 10.1007/s12015-010-9210-x. View

Park I, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A . Disease-specific induced pluripotent stem cells. Cell. 2008; 134(5):877-86. PMC: 2633781. DOI: 10.1016/j.cell.2008.07.041. View

10.

Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews P, Beighton G . Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol. 2007; 25(7):803-16. DOI: 10.1038/nbt1318. View

11.

Prigione A, Fauler B, Lurz R, Lehrach H, Adjaye J . The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells. 2010; 28(4):721-33. DOI: 10.1002/stem.404. View

12.

Katagiri H, Asano T, Ishihara H, Inukai K, Anai M, Yamanouchi T . Mitochondrial diabetes mellitus: prevalence and clinical characterization of diabetes due to mitochondrial tRNA(Leu(UUR)) gene mutation in Japanese patients. Diabetologia. 1994; 37(5):504-10. DOI: 10.1007/s001250050139. View

13.

Mashima Y, Nagano M, Funayama T, Zhang Q, Egashira T, Kudho J . Rapid quantification of the heteroplasmy of mutant mitochondrial DNAs in Leber's hereditary optic neuropathy using the Invader technology. Clin Biochem. 2004; 37(4):268-76. DOI: 10.1016/j.clinbiochem.2003.11.011. View

14.

Inagaki Y, Mashima Y, Fuse N, Ohtake Y, Fujimaki T, Fukuchi T . Mitochondrial DNA mutations with Leber's hereditary optic neuropathy in Japanese patients with open-angle glaucoma. Jpn J Ophthalmol. 2006; 50(2):128-34. DOI: 10.1007/s10384-005-0290-0. View

15.

Hall J, Eis P, Law S, Reynaldo L, Prudent J, Marshall D . Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction. Proc Natl Acad Sci U S A. 2000; 97(15):8272-7. PMC: 26937. DOI: 10.1073/pnas.140225597. View

16.

Ostronoff L, Izquierdo J, Enriquez J, Montoya J, Cuezva J . Transient activation of mitochondrial translation regulates the expression of the mitochondrial genome during mammalian mitochondrial differentiation. Biochem J. 1996; 316 ( Pt 1):183-91. PMC: 1217320. DOI: 10.1042/bj3160183. View

17.

Chou B, Mali P, Huang X, Ye Z, Dowey S, Resar L . Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures. Cell Res. 2011; 21(3):518-29. PMC: 3193421. DOI: 10.1038/cr.2011.12. View

18.

Sone M, Itoh H, Yamahara K, Yamashita J, Yurugi-Kobayashi T, Nonoguchi A . Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol. 2007; 27(10):2127-34. DOI: 10.1161/ATVBAHA.107.143149. View

19.

Fujioka T, Yasuchika K, Nakamura Y, Nakatsuji N, Suemori H . A simple and efficient cryopreservation method for primate embryonic stem cells. Int J Dev Biol. 2004; 48(10):1149-54. DOI: 10.1387/ijdb.041852tf. View

20.

Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M . Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med. 2000; 6(2):88-95. PMC: 1949933. View